A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy

D. H. Thunell, K. D. Tymkiw, G. K. Johnson, S. Joly, K. K. Burnell, J. E. Cavanaugh, K. A. Brogden, J. M. Guthmiller

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Background and Objective: Cytokines and chemokines play an important role in the pathogenesis of periodontal diseases. The objective of this study was to quantitatively assess the effect of initial periodontal therapy on gingival crevicular fluid levels of a comprehensive panel of cytokines and chemokines, including several less extensively studied mediators. Material and Methods: Clinical examinations were performed and gingival crevicular fluid samples obtained from six subjects with generalized severe chronic periodontitis prior to initial periodontal therapy and at re-evaluation (6-8 weeks). Four diseased and two healthy sites were sampled in each subject. Twenty-two gingival crevicular fluid mediators were examined using a multiplex antibody capture and detection platform. Statistical analyses were performed by fitting mixed effects linear models to log-transformed gingival crevicular fluid values. Results: Gingival crevicular fluid interleukin (IL)-1α and IL-1β were the only cytokines to differ in initially diseased vs. initially healthy sites. Following initial therapy, 13 of the 16 detectable cytokines and chemokines decreased significantly in diseased sites, including IL-1α, IL-1β, IL-2, IL-3, IL-6, IL-7, IL-8, IL-12 (p40), CCL5/regulated on activation, normally T cell expressed and secreted (RANTES), eotaxin, macrophage chemotactic protein-1, macrophage inflammatory protein-1α and interferon-γ. At healthy sites, only three of the 16 mediators were significantly altered following therapy. Conclusion: This is the first study, to our knowledge, to evaluate such an extensive panel of gingival crevicular fluid mediators within the same sample prior to and following initial therapy. The results confirm that periodontal therapy effectively reduces pro-inflammatory cytokines and chemokines, including less well-described mediators that may be important in initiation and progression of periodontitis. The multiplex assay will prove useful for future gingival crevicular fluid studies.

Original languageEnglish (US)
Pages (from-to)148-152
Number of pages5
JournalJournal of Periodontal Research
Volume45
Issue number1
DOIs
StatePublished - Feb 1 2010

Fingerprint

Gingival Crevicular Fluid
Immunoassay
Cytokines
Interleukin-1
Chemokines
Therapeutics
Macrophage Inflammatory Proteins
Interleukin-7
Chronic Periodontitis
Interleukin-3
Periodontitis
Periodontal Diseases
Interleukin-12
Interleukin-8
Interferons
Interleukin-2
Linear Models
Interleukin-6
Macrophages
T-Lymphocytes

Keywords

  • Chemokine
  • Cytokine
  • Multiplex immunoassay
  • Periodontal therapy

ASJC Scopus subject areas

  • Periodontics

Cite this

A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. / Thunell, D. H.; Tymkiw, K. D.; Johnson, G. K.; Joly, S.; Burnell, K. K.; Cavanaugh, J. E.; Brogden, K. A.; Guthmiller, J. M.

In: Journal of Periodontal Research, Vol. 45, No. 1, 01.02.2010, p. 148-152.

Research output: Contribution to journalArticle

Thunell, D. H. ; Tymkiw, K. D. ; Johnson, G. K. ; Joly, S. ; Burnell, K. K. ; Cavanaugh, J. E. ; Brogden, K. A. ; Guthmiller, J. M. / A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. In: Journal of Periodontal Research. 2010 ; Vol. 45, No. 1. pp. 148-152.
@article{087bd12287ad4ccdbc877baf0473e43e,
title = "A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy",
abstract = "Background and Objective: Cytokines and chemokines play an important role in the pathogenesis of periodontal diseases. The objective of this study was to quantitatively assess the effect of initial periodontal therapy on gingival crevicular fluid levels of a comprehensive panel of cytokines and chemokines, including several less extensively studied mediators. Material and Methods: Clinical examinations were performed and gingival crevicular fluid samples obtained from six subjects with generalized severe chronic periodontitis prior to initial periodontal therapy and at re-evaluation (6-8 weeks). Four diseased and two healthy sites were sampled in each subject. Twenty-two gingival crevicular fluid mediators were examined using a multiplex antibody capture and detection platform. Statistical analyses were performed by fitting mixed effects linear models to log-transformed gingival crevicular fluid values. Results: Gingival crevicular fluid interleukin (IL)-1α and IL-1β were the only cytokines to differ in initially diseased vs. initially healthy sites. Following initial therapy, 13 of the 16 detectable cytokines and chemokines decreased significantly in diseased sites, including IL-1α, IL-1β, IL-2, IL-3, IL-6, IL-7, IL-8, IL-12 (p40), CCL5/regulated on activation, normally T cell expressed and secreted (RANTES), eotaxin, macrophage chemotactic protein-1, macrophage inflammatory protein-1α and interferon-γ. At healthy sites, only three of the 16 mediators were significantly altered following therapy. Conclusion: This is the first study, to our knowledge, to evaluate such an extensive panel of gingival crevicular fluid mediators within the same sample prior to and following initial therapy. The results confirm that periodontal therapy effectively reduces pro-inflammatory cytokines and chemokines, including less well-described mediators that may be important in initiation and progression of periodontitis. The multiplex assay will prove useful for future gingival crevicular fluid studies.",
keywords = "Chemokine, Cytokine, Multiplex immunoassay, Periodontal therapy",
author = "Thunell, {D. H.} and Tymkiw, {K. D.} and Johnson, {G. K.} and S. Joly and Burnell, {K. K.} and Cavanaugh, {J. E.} and Brogden, {K. A.} and Guthmiller, {J. M.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1111/j.1600-0765.2009.01204.x",
language = "English (US)",
volume = "45",
pages = "148--152",
journal = "Journal of Periodontal Research",
issn = "0022-3484",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy

AU - Thunell, D. H.

AU - Tymkiw, K. D.

AU - Johnson, G. K.

AU - Joly, S.

AU - Burnell, K. K.

AU - Cavanaugh, J. E.

AU - Brogden, K. A.

AU - Guthmiller, J. M.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Background and Objective: Cytokines and chemokines play an important role in the pathogenesis of periodontal diseases. The objective of this study was to quantitatively assess the effect of initial periodontal therapy on gingival crevicular fluid levels of a comprehensive panel of cytokines and chemokines, including several less extensively studied mediators. Material and Methods: Clinical examinations were performed and gingival crevicular fluid samples obtained from six subjects with generalized severe chronic periodontitis prior to initial periodontal therapy and at re-evaluation (6-8 weeks). Four diseased and two healthy sites were sampled in each subject. Twenty-two gingival crevicular fluid mediators were examined using a multiplex antibody capture and detection platform. Statistical analyses were performed by fitting mixed effects linear models to log-transformed gingival crevicular fluid values. Results: Gingival crevicular fluid interleukin (IL)-1α and IL-1β were the only cytokines to differ in initially diseased vs. initially healthy sites. Following initial therapy, 13 of the 16 detectable cytokines and chemokines decreased significantly in diseased sites, including IL-1α, IL-1β, IL-2, IL-3, IL-6, IL-7, IL-8, IL-12 (p40), CCL5/regulated on activation, normally T cell expressed and secreted (RANTES), eotaxin, macrophage chemotactic protein-1, macrophage inflammatory protein-1α and interferon-γ. At healthy sites, only three of the 16 mediators were significantly altered following therapy. Conclusion: This is the first study, to our knowledge, to evaluate such an extensive panel of gingival crevicular fluid mediators within the same sample prior to and following initial therapy. The results confirm that periodontal therapy effectively reduces pro-inflammatory cytokines and chemokines, including less well-described mediators that may be important in initiation and progression of periodontitis. The multiplex assay will prove useful for future gingival crevicular fluid studies.

AB - Background and Objective: Cytokines and chemokines play an important role in the pathogenesis of periodontal diseases. The objective of this study was to quantitatively assess the effect of initial periodontal therapy on gingival crevicular fluid levels of a comprehensive panel of cytokines and chemokines, including several less extensively studied mediators. Material and Methods: Clinical examinations were performed and gingival crevicular fluid samples obtained from six subjects with generalized severe chronic periodontitis prior to initial periodontal therapy and at re-evaluation (6-8 weeks). Four diseased and two healthy sites were sampled in each subject. Twenty-two gingival crevicular fluid mediators were examined using a multiplex antibody capture and detection platform. Statistical analyses were performed by fitting mixed effects linear models to log-transformed gingival crevicular fluid values. Results: Gingival crevicular fluid interleukin (IL)-1α and IL-1β were the only cytokines to differ in initially diseased vs. initially healthy sites. Following initial therapy, 13 of the 16 detectable cytokines and chemokines decreased significantly in diseased sites, including IL-1α, IL-1β, IL-2, IL-3, IL-6, IL-7, IL-8, IL-12 (p40), CCL5/regulated on activation, normally T cell expressed and secreted (RANTES), eotaxin, macrophage chemotactic protein-1, macrophage inflammatory protein-1α and interferon-γ. At healthy sites, only three of the 16 mediators were significantly altered following therapy. Conclusion: This is the first study, to our knowledge, to evaluate such an extensive panel of gingival crevicular fluid mediators within the same sample prior to and following initial therapy. The results confirm that periodontal therapy effectively reduces pro-inflammatory cytokines and chemokines, including less well-described mediators that may be important in initiation and progression of periodontitis. The multiplex assay will prove useful for future gingival crevicular fluid studies.

KW - Chemokine

KW - Cytokine

KW - Multiplex immunoassay

KW - Periodontal therapy

UR - http://www.scopus.com/inward/record.url?scp=74549124780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549124780&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0765.2009.01204.x

DO - 10.1111/j.1600-0765.2009.01204.x

M3 - Article

C2 - 19602112

AN - SCOPUS:74549124780

VL - 45

SP - 148

EP - 152

JO - Journal of Periodontal Research

JF - Journal of Periodontal Research

SN - 0022-3484

IS - 1

ER -